W. Schulte

A Genomics-Based Classification of Human Lung Tumors

G. Getz, S. Carter, D. Hayes, 2013, Science Translational Medicine.

Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients

L. Bubendorf, R. Hein, W. Engel-Riedel, 2016, Journal of Thoracic Oncology.

Genetic Heterogeneity of MET-aberrant Non-Small Cell Lung Cancer and its Impact on the Outcome of Immunotherapy.

N. Reinmuth, J. Panse, J. Wolf, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

M. Hellmich, T. Zander, Y. Ko, 2014, Oncotarget.

Ampli fi cation Status in Therapy-Naïve Adeno-and Squamous Cell Carcinomas of the Lung

T. Zander, Y. Ko, K. Hekmat, 2015 .

MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

T. Zander, Y. Ko, K. Hekmat, 2014, Clinical Cancer Research.

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

T. Zander, Y. Ko, K. Hekmat, 2012, Modern Pathology.

K‐ras Mutation Subtypes in NSCLC and Associated Co‐occuring Mutations in Other Oncogenic Pathways

M. Hellmich, Roman K. Thomas, Y. Ko, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin

G. Nickenig, D. Skowasch, C. Pizarro, 2016, International Journal of COPD.

MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

T. Zander, Y. Ko, K. Hekmat, 2014, Clinical Cancer Research.